BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Total Current Liabilities

Track COSCIENS Biopharma's total current liabilities ($5.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$5.53M
↓ 44.11% YoYΔ $-4.37M vs prior year quarter

Peer average

Loading

COSCIENS Biopharma Total Current Liabilities History

Loading

COSCIENS Biopharma vs. peers: Total Current Liabilities Comparison

Loading

COSCIENS Biopharma Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSCIENS Biopharma (CSCI) FAQ

COSCIENS Biopharma (CSCI) currently reports a total current liabilities of $5.5M as of June 2025. That compares with $9.9M in the prior-year period — down 44.1% year over year. Use the charts on this page to explore COSCIENS Biopharma's total current liabilities history and peer comparisons.

COSCIENS Biopharma's total current liabilities decreased from $9.9M to $5.5M — a 44.1% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSCIENS Biopharma reported $5.5M in total current liabilities as of June 2025. That compares with $9.9M in the prior-year period — down 44.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $5.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following CSCI for alerts when major investors trade the stock.